Investors fear the company may underperform the broader indu...
Investors fear the company may underperform the broader industry soon, despite strong revenue growth. Shareholders think recent performance has peaked, accepting lower selling prices. Underlying risks to profitability are pressuring the P/S ratio.
Austar Lifesciences Limited (HKG:6118) Stock Rockets 31% But Many Are Still Ignoring The Company
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment